JP2020522525A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522525A5 JP2020522525A5 JP2019566909A JP2019566909A JP2020522525A5 JP 2020522525 A5 JP2020522525 A5 JP 2020522525A5 JP 2019566909 A JP2019566909 A JP 2019566909A JP 2019566909 A JP2019566909 A JP 2019566909A JP 2020522525 A5 JP2020522525 A5 JP 2020522525A5
- Authority
- JP
- Japan
- Prior art keywords
- human patient
- item
- pharmaceutical composition
- compound
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCc1c(*)ccc(OC)c1COc(cc(*(C(c1c(C(*)=O)[n]cc1*1)O)C1=O)c(*)c1)c1OC Chemical compound CCc1c(*)ccc(OC)c1COc(cc(*(C(c1c(C(*)=O)[n]cc1*1)O)C1=O)c(*)c1)c1OC 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023043718A JP7485815B2 (ja) | 2017-06-05 | 2023-03-20 | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762515232P | 2017-06-05 | 2017-06-05 | |
| US62/515,232 | 2017-06-05 | ||
| PCT/EP2018/064767 WO2018224497A1 (en) | 2017-06-05 | 2018-06-05 | Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023043718A Division JP7485815B2 (ja) | 2017-06-05 | 2023-03-20 | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522525A JP2020522525A (ja) | 2020-07-30 |
| JP2020522525A5 true JP2020522525A5 (enExample) | 2021-07-26 |
| JP7292566B2 JP7292566B2 (ja) | 2023-06-19 |
Family
ID=62636157
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019566909A Active JP7292566B2 (ja) | 2017-06-05 | 2018-06-05 | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
| JP2023043718A Active JP7485815B2 (ja) | 2017-06-05 | 2023-03-20 | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023043718A Active JP7485815B2 (ja) | 2017-06-05 | 2023-03-20 | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11759464B2 (enExample) |
| EP (2) | EP4509173A3 (enExample) |
| JP (2) | JP7292566B2 (enExample) |
| KR (1) | KR102884301B1 (enExample) |
| CN (1) | CN110996957A (enExample) |
| AU (2) | AU2018280741B2 (enExample) |
| CA (1) | CA3066188A1 (enExample) |
| DK (1) | DK3634419T3 (enExample) |
| EA (1) | EA201992812A1 (enExample) |
| ES (1) | ES3018358T3 (enExample) |
| FI (1) | FI3634419T3 (enExample) |
| HR (1) | HRP20250390T1 (enExample) |
| HU (1) | HUE070907T2 (enExample) |
| MX (2) | MX2019014482A (enExample) |
| PL (1) | PL3634419T3 (enExample) |
| PT (1) | PT3634419T (enExample) |
| SG (1) | SG11201911599XA (enExample) |
| WO (1) | WO2018224497A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4223298A3 (en) | 2013-03-15 | 2023-08-16 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
| EA201992612A1 (ru) | 2017-06-05 | 2020-05-20 | Обсева С.А. | Схемы применения антагониста гонадотропин-высвобождающего гормона для лечения эндометриоза |
| DK3634419T3 (da) | 2017-06-05 | 2025-03-31 | Kissei Pharmaceutical | Doseringsregime omfattende en gonadotropin-frigørende hormon-antagonist til behandling af fibromer i uterus og reduktion af menstruationsblodtab |
| US11690854B2 (en) | 2018-04-19 | 2023-07-04 | Abbvie Inc. | Methods of treating heavy menstrual bleeding |
| CA3107597A1 (en) * | 2018-08-01 | 2020-02-06 | Abbvie Inc. | Dosing regimens for elagolix |
| MA54058A (fr) | 2018-10-29 | 2021-09-08 | ObsEva SA | Compositions et méthodes de traitement de l'endométriose interne et de l'endométriose rectovaginale |
| JP7459086B2 (ja) * | 2018-11-07 | 2024-04-01 | キッセイ薬品工業株式会社 | エストロゲン依存性障害の治療のための組成物及び方法 |
| EP4009976A1 (en) * | 2019-08-08 | 2022-06-15 | ObsEva S.A. | Gnrh antagonists for the treatment of estrogen-dependent disorders |
| AU2020325655B2 (en) * | 2019-08-08 | 2025-09-11 | Kissei Pharmaceutical Co., Ltd. | Compositions and methods for the treatment of estrogen-dependent disorders |
| KR20210155350A (ko) | 2020-06-15 | 2021-12-22 | 한상왕 | 녹차 추출물 및 비타민 d3를 유효성분으로 포함하는 자궁근종 개선용 조성물 |
| CN115232144B (zh) * | 2021-04-22 | 2024-04-02 | 长春金赛药业有限责任公司 | 含氮稠环类衍生物、药物组合物及其制备方法和应用 |
| KR102738115B1 (ko) | 2024-03-25 | 2024-12-05 | 한상왕 | 자궁근종 예방, 개선 또는 치료용 약학 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109171B2 (en) * | 2000-02-28 | 2006-09-19 | Praecis Pharmaceuticals Inc. | Methods for treating FSH related conditions with GnRH antagonists |
| RU2418803C2 (ru) * | 2005-10-19 | 2011-05-20 | Киссеи Фармасьютикал Ко., Лтд. | Конденсированное гетероциклическое производное, содержащая его лечебная композиция и ее применение в медицине |
| EP2535342B1 (en) * | 2010-02-10 | 2014-08-06 | Kissei Pharmaceutical Co., Ltd. | Salt of fused heterocyclic derivative and crystal thereof |
| JP6268093B2 (ja) | 2012-09-14 | 2018-01-24 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
| EP4223298A3 (en) | 2013-03-15 | 2023-08-16 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
| BR112019002513A2 (pt) | 2016-08-08 | 2019-05-14 | Kissei Pharmaceutical Co., Ltd. | uso e dosagem de agentes terapêuticos para endometriose |
| WO2018060501A2 (en) | 2016-09-30 | 2018-04-05 | Myovant Sciences Gmbh | Methods of treating uterine fibroids and endometriosis |
| EA201992612A1 (ru) | 2017-06-05 | 2020-05-20 | Обсева С.А. | Схемы применения антагониста гонадотропин-высвобождающего гормона для лечения эндометриоза |
| DK3634419T3 (da) | 2017-06-05 | 2025-03-31 | Kissei Pharmaceutical | Doseringsregime omfattende en gonadotropin-frigørende hormon-antagonist til behandling af fibromer i uterus og reduktion af menstruationsblodtab |
| JP7459086B2 (ja) | 2018-11-07 | 2024-04-01 | キッセイ薬品工業株式会社 | エストロゲン依存性障害の治療のための組成物及び方法 |
-
2018
- 2018-06-05 DK DK18731976.9T patent/DK3634419T3/da active
- 2018-06-05 CA CA3066188A patent/CA3066188A1/en active Pending
- 2018-06-05 WO PCT/EP2018/064767 patent/WO2018224497A1/en not_active Ceased
- 2018-06-05 MX MX2019014482A patent/MX2019014482A/es unknown
- 2018-06-05 JP JP2019566909A patent/JP7292566B2/ja active Active
- 2018-06-05 ES ES18731976T patent/ES3018358T3/es active Active
- 2018-06-05 HR HRP20250390TT patent/HRP20250390T1/hr unknown
- 2018-06-05 US US16/619,702 patent/US11759464B2/en active Active
- 2018-06-05 PT PT187319769T patent/PT3634419T/pt unknown
- 2018-06-05 EP EP24221894.9A patent/EP4509173A3/en active Pending
- 2018-06-05 MX MX2023013582A patent/MX2023013582A/es unknown
- 2018-06-05 PL PL18731976.9T patent/PL3634419T3/pl unknown
- 2018-06-05 EP EP18731976.9A patent/EP3634419B1/en active Active
- 2018-06-05 EA EA201992812A patent/EA201992812A1/ru unknown
- 2018-06-05 SG SG11201911599XA patent/SG11201911599XA/en unknown
- 2018-06-05 CN CN201880050807.2A patent/CN110996957A/zh active Pending
- 2018-06-05 FI FIEP18731976.9T patent/FI3634419T3/fi active
- 2018-06-05 KR KR1020197038980A patent/KR102884301B1/ko active Active
- 2018-06-05 HU HUE18731976A patent/HUE070907T2/hu unknown
- 2018-06-05 AU AU2018280741A patent/AU2018280741B2/en active Active
-
2023
- 2023-03-20 JP JP2023043718A patent/JP7485815B2/ja active Active
- 2023-09-11 US US18/244,773 patent/US20240000785A1/en active Pending
-
2024
- 2024-03-14 AU AU2024201694A patent/AU2024201694A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5468736A (en) | Hormone replacement therapy | |
| JP3113269B2 (ja) | 骨粗鬆症治療剤 | |
| KR100365879B1 (ko) | 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제 | |
| JP7485815B2 (ja) | 子宮筋腫を治療し、月経失血を低下させるゴナドトロピン放出ホルモンアンタゴニスト投与計画 | |
| JPH09502194A (ja) | 少なくとも１種のプロゲストーゲンおよび少なくとも１種のエストロゲンを含む、代替療法用製剤 | |
| HU214598B (hu) | Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására | |
| JP2020522571A5 (enExample) | ||
| JP2022506368A5 (enExample) | ||
| ES2208518T3 (es) | Medio y metodo anticonceptivo hormonal. | |
| KR20000048981A (ko) | 에스트로겐 화합물 및 프로게스테론 화합물로 이루어진 호르몬 조성물 | |
| JP2003048836A (ja) | 効能を保持し無月経を引き起こす超低用量の経口避妊薬 | |
| EP0474374A1 (en) | Method for treatment of bone wasting diseases using a progestin | |
| JP3054780B2 (ja) | 受精の阻止及び防止方法 | |
| WO2000021511A2 (en) | Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis | |
| JP2005527574A (ja) | ホルモン補充療法におけるトリメゲストンと組み合わせた結合型エストロゲンの使用 | |
| RU2234321C2 (ru) | Применение антипрогестагенов в комбинированной терапии | |
| AU6621994A (en) | Method and composition for treatment of osteoporosis | |
| Briggs et al. | Clinical and biochemical investigations of a variable-dose combined type oral contraceptive | |
| JPH11501649A (ja) | 閉経周辺期及び閉経前期にある女性に対する徐放性避妊薬としての及びホルモン補充療法に使用する１月用注射薬 | |
| Tankeyoon et al. | 221. Metabolic effects of a long acting injectable steroid contraceptive | |
| Laumas et al. | 220. Serum levels of norethindrone in women after insertion of silastic implant releasing norethindrone acetate and their effect on the endogenous progesterone levels | |
| MXPA00005593A (en) | Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis | |
| MXPA01008772A (en) | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding | |
| HK1115537B (en) | A use of hydroalcoholic gel in the manufacture of medicine | |
| HK1115537A1 (en) | A use of hydroalcoholic gel in the manufacture of medicine |